|
Symbol
|
IHTEFG | HZJEFG | RMBFAV | Z09YGZ | PBURCH | RMA3QV | RMBRKV | ERORCH | ABMUTQ | PRZRCH | Z0ARNZ | CQWBKB | PWCRCH | LYXRCH | LYZRCH | LZJRCH | LZMRCH | UJERWU | RMAT9V | RMBGJV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Reverse Convertible | Reverse Convertible | Multi Vonti | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible | Autocallable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | GOAL | Reverse Convertible | Multi Vonti |
|
Underlying
|
Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche PS / Sika AG | Kühne & Nagel Intl. AG / Lonza Group N / Sika AG | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Logitech International SA / Lonza Group N / Partners Group Hldg. AG / Sika AG | Lonza Group N / SGS S.A. Ltd. / Swisscom N | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG | Holcim AG / Swiss RE AG / Lonza Group N | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG | Alcon / Lonza Group N / Partners Group Hldg. AG | Alcon / Lonza Group N / Novartis AG / Straumann Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
28.06.2029 | 02.11.2026 | 13.07.2026 | 27.08.2027 | 21.07.2026 | 09.11.2026 | 05.11.2026 | 06.11.2026 | 20.12.2029 | 24.02.2027 | 25.08.2026 | 13.03.2028 | 27.06.2029 | 07.10.2026 | 14.07.2027 | 24.07.2026 | 31.07.2026 | 02.08.2027 | 12.08.2026 | 19.08.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Strike price
|
176.28 | 182.298 | 208.20 | 179.883 | 57.988 | 56.14 | 197.80 | 141.44 | 6.7665 | 416.78 | 463.386 | 78.705 | 89.05 | 831.20 | 361.14 | 67.425 | 110.6625 | 390.663 | 828.5956 | 51.80 |
| Max. yield p.a. | - | - | 550.27% | 18.43% | - | 23.34% | 62.98% | 4.39% | 12.18% | 5.05% | 5.10% | 7.45% | 7.16% | 91.17% | 2.67% | 27.39% | -1.39% | 9.46% | 195.16% | 11.25% |
| Bid | 92.90 | 86.83 | 78.70 | 86.71 | 93.64 | 93.20 | 83.30 | 99.55 | 80.47 | 98.81 | 99.48 | 95.59 | 93.00 | 82.06 | 99.67 | 97.13 | 99.86 | 97.50 | 78.80 | 93.70 |
| Ask | - | - | 79.70 | 87.61 | - | 94.00 | 84.30 | 100.35 | 81.27 | 99.61 | 100.38 | 96.39 | 93.80 | 82.86 | 100.47 | 97.93 | 100.66 | 98.50 | 79.80 | 94.50 |